Symeres, a European drug discovery contract research organization (CRO) and contract development and manufacturing organization (CDMO), has acquired Organix Inc., a U.S.-based specialized organic chemistry services provider with a focus on lipids. Organix, based in the Boston, MA area, is a provider of high-quality organic chemistry services dedicated to the discovery and preclinical stage of the drug discovery value chain. Its revenue is mainly generated from the sale of specialized and comp...